Please login to the form below

Not currently logged in

Shire promotes David Colpman to fill global business development role

He replaces Barbara Deptula, who is retiring from the biopharma company

Shire David Colpman global business developmentShire has made two senior promotions, appointing David Colpman to lead its global business development team and elevating Ann Judge to its leadership team.

Colpman will take over from Barbara Deptula, who is retiring after eight years at the helm of the Dublin-based biopharmaceutical company's business development team.

He has been with Shire for over 12 years, leading many of its significant deals, and before that worked at Glaxo Wellcome, Novo Nordisk and Boots Pharmaceuticals in a variety of business development and commercial roles.

Colpman began his industry career at ICI (now AstraZeneca) in formulation and manufacturing and in his new role will report to Shire's chief executive Angus Russell.

Meanwhile Shire has also appointed Ann Judge, currently senior vice president of its global Human Resources team, to the Shire leadership team.

Judge has over 20 years of global HR experience in the pharmaceutical, chemical, and oil and gas industries, having begun her career with Dow Chemical. She joined Shire to lead its global HR team in late 2010, after spending six years with Wyeth Pharmaceuticals (now part of Pfizer).

6th June 2012


Featured jobs

Subscribe to our email news alerts


Add my company
Complete Medical Communications (CMC)

CMC is a leading global agency dedicated to healthcare communications across the lifecycle. We combine scientific acumen, excellence in delivery...

Latest intelligence

Beyond the event
Anthill Agency and Actando partnership to Transform Pharma's Digital Skills
Anthill Agency, a leading life sciences digital agency, today announced the launch of the Anthill Academy™ and partnership with Actando's PharmAcademy....
Is the pharma business model ready for precision medicine?
Precision medicine promises to revolutionise patient outcomes and reduce costs for industry but is pharma ready for it? Blue Latitude Health co-founder Head of Strategy Fred Bassett explores the challenges...